Rhabdomyosarcoma · 5 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
VA Variant #01 | — | R 51 140 | 84d | — | — | — | — | — |
VAC Variant #01 | — | R 28 273 | 7d | — | — | — | — | — |
VAI Variant #02 | — | R 26 252 | 21d | — | — | — | — | — |
VIE Variant #01 | — | R 19 409 | 21d | — | — | — | — | — |
VI, then VDC/IE, then VAC, then VI Partial | — | — | — | — | — | — | — | — |
5 of 5 regimens shown